US Stock MarketDetailed Quotes
XERS Xeris Pharmaceuticals
- 2.670
- +0.160+6.37%
Close Sep 9 16:00 ET
- 2.660
- -0.010-0.37%
Post 16:53 ET
397.83MMarket Cap-6357P/E (TTM)
2.746High2.510Low1.92MVolume2.510Open2.510Pre Close5.14MTurnover1.35%Turnover RatioLossP/E (Static)149.00MShares3.26052wk High-20.70P/B378.82MFloat Cap1.46052wk Low--Dividend TTM141.88MShs Float27.983Historical High--Div YieldTTM9.38%Amplitude0.970Historical Low2.679Avg Price1Lot Size
Xeris Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 26.46%48.07M | 22.42%40.64M | 48.68%163.91M | 33.93%44.39M | 62.56%48.32M | 50.19%38.01M | 50.39%33.2M | 122.32%110.25M | 54.67%33.14M | 168.76%29.73M |
| Operating revenue | 26.46%48.07M | 22.42%40.64M | 48.68%163.91M | 33.93%44.39M | 62.56%48.32M | 50.19%38.01M | 50.39%33.2M | 122.32%110.25M | 54.67%33.14M | 168.76%29.73M |
| Cost of revenue | 3.11%7.79M | 12.26%5.97M | 26.56%28.65M | 20.33%7.57M | 55.91%8.2M | 57.07%7.56M | -15.21%5.32M | 69.95%22.63M | 28.68%6.29M | 63.35%5.26M |
| Gross profit | 32.25%40.28M | 24.36%34.67M | 54.39%135.27M | 37.12%36.82M | 63.99%40.12M | 48.58%30.45M | 76.44%27.88M | 141.55%87.61M | 62.35%26.85M | 212.05%24.47M |
| Operating expense | 4.37%48.46M | 18.85%48.91M | 5.74%179.28M | 11.04%46.66M | 4.13%45.03M | 17.81%46.43M | -8.29%41.15M | 11.97%169.55M | -35.16%42.02M | 34.31%43.25M |
| Selling and administrative expenses | 6.27%39.99M | 14.21%38.38M | 6.06%146.1M | 9.35%37.57M | 8.11%37.29M | 14.10%37.64M | -6.43%33.61M | 9.57%137.75M | -36.59%34.36M | 29.98%34.49M |
| Research and development costs | -5.39%5.76M | 61.66%7.82M | 6.56%22.34M | 28.80%6.38M | -16.70%5.03M | 63.72%6.09M | -22.59%4.84M | -16.67%20.97M | -50.85%4.96M | 6.71%6.04M |
| Depreciation amortization depletion | 0.00%2.71M | 0.00%2.71M | 0.00%10.84M | 0.00%2.71M | 0.00%2.71M | 0.00%2.71M | 0.00%2.71M | 1,871.45%10.84M | 392.91%2.71M | --2.71M |
| -Depreciation and amortization | 0.00%2.71M | 0.00%2.71M | 0.00%10.84M | 0.00%2.71M | 0.00%2.71M | 0.00%2.71M | 0.00%2.71M | 1,871.45%10.84M | 392.91%2.71M | --2.71M |
| Operating profit | 48.76%-8.19M | -7.29%-14.25M | 46.29%-44.01M | 35.13%-9.84M | 73.84%-4.91M | 15.53%-15.98M | 54.33%-13.28M | 28.84%-81.94M | 68.57%-15.17M | 22.90%-18.78M |
| Net non-operating interest income expense | -25.79%-6.67M | -3.93%-5.11M | -89.67%-21.86M | -134.19%-5.91M | -62.81%-5.73M | -63.08%-5.31M | -42.37%-4.92M | -67.82%-11.52M | -46.23%-2.52M | -103.06%-3.52M |
| Non-operating interest income | 5.56%1.29M | 47.92%1.92M | 84.29%4.75M | -39.93%1.11M | 137.50%1.12M | 527.18%1.22M | 1,811.76%1.3M | 723.64%2.58M | 2,532.86%1.84M | 615.15%472K |
| Non-operating interest expense | 22.00%7.96M | 13.13%7.03M | 88.69%26.61M | 60.71%7.02M | 71.65%6.85M | 89.33%6.53M | 76.54%6.22M | 96.41%14.1M | 143.15%4.37M | 121.86%3.99M |
| Other net income (expense) | -21.25%604K | -49.89%681K | 190.23%2.36M | -51.97%2.13M | -1,586.61%-1.89M | 117.61%767K | 185.20%1.36M | -273.22%-2.62M | 658.13%4.43M | 56.79%127K |
| Gain on sale of security | 121.43%3K | --4K | -99.94%1K | -114.29%-2K | 88.89%17K | -102.71%-14K | ---- | 350.71%1.76M | 101.77%14K | -88.89%9K |
| Special income (charges) | -23.05%601K | -50.18%677K | 153.95%2.36M | -51.77%2.13M | -1,714.41%-1.91M | 116.03%781K | 148.26%1.36M | ---4.38M | --4.41M | --118K |
| -Less：Restructuring and merger&acquisition | 23.05%-601K | -147.76%-3.37M | -264.71%-5.2M | 51.77%-2.13M | -689.83%-932K | -116.03%-781K | -148.26%-1.36M | --3.16M | ---4.41M | ---118K |
| -Less:Other special charges | ---- | --2.69M | 131.97%2.84M | --0 | --2.84M | ---- | ---- | --1.22M | --0 | ---- |
| Income before tax | 30.52%-14.26M | -10.92%-18.67M | 33.91%-63.5M | -2.70%-13.63M | 43.50%-12.53M | 22.65%-20.52M | 50.67%-16.83M | 21.71%-96.08M | 73.88%-13.27M | 14.76%-22.17M |
| Income tax | 210.96%749K | 307K | 12.29%-1.25M | 30.18%-236K | 0.29%-338K | -99.12%-675K | 0 | -1.42M | -338K | -339K |
| Net income | 24.38%-15.01M | -12.75%-18.98M | 34.23%-62.26M | -3.56%-13.39M | 44.17%-12.19M | 24.22%-19.84M | 50.07%-16.83M | 22.87%-94.66M | 74.54%-12.93M | 16.06%-21.83M |
| Net income continuous Operations | 24.38%-15.01M | -12.75%-18.98M | 34.23%-62.26M | -3.56%-13.39M | 44.17%-12.19M | 24.22%-19.84M | 50.07%-16.83M | 22.87%-94.66M | 74.54%-12.93M | 16.06%-21.83M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 24.38%-15.01M | -12.75%-18.98M | 34.23%-62.26M | -3.56%-13.39M | 44.17%-12.19M | 24.22%-19.84M | 50.07%-16.83M | 22.87%-94.66M | 74.54%-12.93M | 16.06%-21.83M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 24.38%-15.01M | -12.75%-18.98M | 34.23%-62.26M | -3.56%-13.39M | 44.17%-12.19M | 24.22%-19.84M | 50.07%-16.83M | 22.87%-94.66M | 74.54%-12.93M | 16.06%-21.83M |
| Basic earnings per share | 28.57%-0.1 | -16.67%-0.14 | 35.71%-0.45 | 10.00%-0.09 | 43.75%-0.09 | 26.32%-0.14 | 52.00%-0.12 | 54.84%-0.7 | 76.19%-0.1 | 58.97%-0.16 |
| Diluted earnings per share | 28.57%-0.1 | -16.67%-0.14 | 35.71%-0.45 | 10.00%-0.09 | 43.75%-0.09 | 26.32%-0.14 | 52.00%-0.12 | 54.84%-0.7 | 76.19%-0.1 | 58.97%-0.16 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg